Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
Biotech
Regenxbio-AbbVie in-office gene therapy clears phase 2 test
Interim phase 2 data suggest the prospect can be given safely at the doctor’s office, opening up a convenient delivery option for the wet AMD therapy.
Nick Paul Taylor
Jan 17, 2024 9:42am
New prime editor delivery particles help restore vision in mice
Jan 9, 2024 7:00am
FDA recommends avoiding plastic syringes made in China
Dec 1, 2023 11:47am
GLP-1 drug hydrogels could reduce shots to 3 times a year
Nov 28, 2023 11:30am
Veins, VEINS! Access Vascular grabs $22M for catheter rollout
Oct 31, 2023 2:08pm
HIV drug hydrogel extends treatment longevity to 6 weeks
Sep 25, 2023 2:00pm